Tetralogy of Fallot
© Bailliard and Anderson; licensee BioMed Central Ltd. 2009
Received: 26 November 2008
Accepted: 13 January 2009
Published: 13 January 2009
Tetralogy of Fallot is a congenital cardiac malformation that consists of an interventricular communication, also known as a ventricular septal defect, obstruction of the right ventricular outflow tract, override of the ventricular septum by the aortic root, and right ventricular hypertrophy.
This combination of lesions occurs in 3 of every 10,000 live births, and accounts for 7–10% of all congenital cardiac malformations.
Patients nowadays usually present as neonates, with cyanosis of varying intensity based on the degree of obstruction to flow of blood to the lungs.
The aetiology is multifactorial, but reported associations include untreated maternal diabetes, phenylketonuria, and intake of retinoic acid. Associated chromosomal anomalies can include trisomies 21, 18, and 13, but recent experience points to the much more frequent association of microdeletions of chromosome 22. The risk of recurrence in families is 3%.
Useful diagnostic tests are the chest radiograph, electrocardiogram, and echocardiogram. The echocardiogram establishes the definitive diagnosis, and usually provides sufficient information for planning of treatment, which is surgical. Approximately half of patients are now diagnosed antenatally.
Differential diagnosis includes primary pulmonary causes of cyanosis, along with other cyanotic heart lesions, such as critical pulmonary stenosis and transposed arterial trunks. Neonates who present with ductal-dependent flow to the lungs will receive prostaglandins to maintain ductal patency until surgical intervention is performed. Initial intervention may be palliative, such as surgical creation of a systemic-to-pulmonary arterial shunt, but the trend in centres of excellence is increasingly towards neonatal complete repair. Centres that undertake neonatal palliation will perform the complete repair at the age of 4 to 6 months. Follow-up in patients born 30 years ago shows a rate of survival greater than 85%. Chronic issues that now face such adults include pulmonary regurgitation, recurrence of pulmonary stenosis, and ventricular arrhythmias. As the strategies for surgical and medical management have progressed, the morbidity and mortality of those born with tetralogy of Fallot in the current era is expected to be significantly improved.
Tetralogy of Fallot occurs in 3 of every 10,000 live births. It is the commonest cause of cyanotic cardiac disease in patients beyond the neonatal age, and accounts for up to one-tenth of all congenital cardiac lesions .
The embryological basis of the combination of lesions is antero-cephalad deviation of the developing outlet ventricular septum, or its fibrous remnant should this septum fail to muscularise. Such deviation, however, can be found in the absence of subpulmonary obstruction, as in the so-called Eisenmenger ventricular septal defect . So as to produce the features of tetralogy of Fallot, therefore, it is also necessary to have abnormal morphology of the septoparietal trabeculations that encircle the subpulmonary outflow tract . The combination of the deviated outlet septum and the hypertrophied septoparietal trabeculations produce the characteristic right ventricular outflow tract obstruction of tetralogy of Fallot (Figure 1). The deviation of the muscular outlet septum is also responsible for creating the malalignment type ventricular septal defect, and results in the aortic override. The associated hypertrophy of the right ventricular myocardium is the haemodynamic consequence of the anatomical lesions created by the deviated outlet septum.
The ventricular septal defect
The size of the ventricular septal defect can vary, but in almost all instances, the interventricular communication is unrestrictive, allowing for bidirectional shunting .
Override of the aorta
Because of the displacement of the malaligned outlet septum into the right ventricle, the aortic root, of necessity, overrides the muscular ventricular septum. In the setting of significant subpulmonary obstruction, shunting across the interventricular communication is predominantly from right-to-left, which promotes ejection of deoxygenated blood into the systemic circulation. The chronic volume load sustained by the overriding aorta is implicated in the dilation of the aortic root noted in adults with tetralogy of Fallot [7, 8].
The antero-cephalad deviation of the outlet septum, coupled with an anomalous relationship to the septoparietal trabeculations, results in a narrowing of the subpulmonary outflow tract. The obstructive muscular subpulmonary area thus created is a dynamic entity. The degree of stenosis created can be exacerbated by catecholamines, or a state of low intravascular volume, predisposing the patients to sudden and acute episodes of desaturation known as hypercyanotic spells [9, 10].
The obstruction to flow into the lungs often extends beyond the subpulmonary outflow tract itself. The pulmonary valve may be hypoplastic, with abnormally functioning leaflets, often having a bifoliate configuration. Not infrequently, the pulmonary trunk, and the right and left pulmonary arteries, are diminutive, exhibiting additional focal areas of narrowing .
Anatomical variants of Tetralogy of Fallot, and associated anomalies
Tetralogy of Fallot with pulmonary atresia
Although the collateral arteries do not depend on prostaglandin for patency, they have the potential to stenose over time. In other instances, large collateral arteries can provide unrestricted flow to the lungs, thus producing hypertensive pulmonary vasculature. The long-term management of the pulmonary supply in patients with tetralogy of Fallot and pulmonary atresia, therefore, is complicated.
Tetralogy of Fallot with absent pulmonary valve
Malalignment of the outlet septum with rudimentary formation of the leaflets of the pulmonary valve, so-called absent pulmonary valve syndrome, is seen in around one-twentieth of those alleged to have tetralogy of Fallot . The presence of rudimentary valvar leaflets arrayed in circular fashion at the ventriculo-pulmonary junction results in free pulmonary regurgitation throughout foetal life. The end result is that the chronic volume load of the right ventricle is transmitted to the pulmonary arteries, with concomitant dilation of these vessels. In severe cases, patients present with inspiratory and expiratory stridor due to compression of the airways by the dilated pulmonary arteries. Although compression and obstruction of the airways are partly responsible for cyanosis, there is also focal narrowing at the ventriculo-pulmonary junction, contributing to the hypoxaemia in these patients [12, 14]. In most instances, but certainly not all, the arterial duct is also absent.
Tetralogy of Fallot with double outlet right ventricle
With pronounced aortic override, the aorta becomes more committed to the right ventricle than to the left ventricle, resulting in many instances in the ventriculo-arterial connection of double outlet right ventricle. Although the physiology on presentation may not be altered, there are important implications for surgical repair . Patients with the aorta originating predominantly from the right ventricle are at greater risk of developing obstruction to the newly created left ventricular outflow tract, the latter produced by the patch which closes the ventricular septal defect while tunneling the left ventricle to the aorta. This patch, of necessity, is appreciably longer than when the aorta arises mostly from the left ventricle [5, 15].
Tetralogy of Fallot with atrioventricular septal defect
An atrioventricular septal defect combined with a common atrioventricular junction is found in 2% of patients with tetralogy of Fallot . The presentation and initial medical management remain unchanged, but surgical repair and post-operative care are more complex (see Management, [16, 17]).
Anomalous origins of the coronary arteries occur in up to one-sixth of patients, and should be documented prior to surgical repair. The most common and relevant anomaly is origin of the left anterior descending artery from the right coronary artery, with the anomalous artery then coursing anterior to the subpulmonary outflow tract, a potential site of surgical incision.
Other associated lesions include atrial septal defects, and additional ventricular septal defects, the latter usually being muscular. Straddling and overriding of the tricuspid valve may also occur, which will complicate the closure of the ventricular septal defect. An important finding when there is overriding of the orifice of the tricuspid valve is the anomalous location of the atrioventricular conduction tissues . A right aortic arch, which is of no haemodynamic consequence, is present in one-quarter of patients with tetralogy of Fallot.
Clinical manifestations and diagnostic work-up
The initial presentation of tetralogy of Fallot varies depending on the severity of the obstruction of blood flow to the lungs. Most patients will present in the neonatal period with mild-to-moderate cyanosis, but typically without respiratory distress. More uncommonly, patients with very mild right ventricular outflow tract obstruction at birth may be diagnosed at a couple months of age as the obstruction worsens resulting in newly noticed cyanosis and a louder murmur. Because patients with tetralogy of Fallot have obstruction to pulmonary blood flow, they will not present with signs of heart failure such as failure to thrive. Irritability and lethargy are rarely seen in patients with tetralogy of Fallot except in the setting of a hypercyanotic spell. Clubbing is also highly unusual in the modern era since newly diagnosed patients undergo surgical repair before clubbing has time to develop.
The second heart sound in patients with tetralogy of Fallot may be single and loud, and a harsh systolic ejection murmur will be present, emanating from the obstructed subpulmonary outflow tract. Flow across the interventricular communication in tetralogy of Fallot is usually not turbulent, and therefore not audible. Patients with severe obstruction, and very little antegrade flow across the subpulmonary outflow tract, will be more significantly cyanotic and have a less prominent murmur.
Once the lesion is suspected, an electrocardiogram and chest radiograph should be performed. The electrocardiogram will demonstrate right axis deviation and prominent right ventricular forces, with large R waves in the anterior precordial leads and large S waves in the lateral precordial leads . Although the electrocardiogram is similar to that of a normal newborn, the right ventricular hypertrophy and right axis deviation will not normalize in a patient with tetralogy of Fallot. The classical chest radiograph will demonstrate a boot-shaped cardiac silhouette. This is due to upward displacement of the right ventricular apex as a consequence of the right ventricular hypertrophy, and a narrowing of the mediastinal shadow due to the hypoplastic pulmonary outflow tract.
The hypercyanotic spell [9, 10] is characterised by a sudden and striking decrease in the saturation of oxygen due to acute and complete, or near complete, obstruction of the subpulmonary outflow tract. Not all patients with tetralogy of Fallot will have hypercyanotic spells. The spells typically begin to occur at approximately a couple months of age at times of agitation or decreased hydration, both of which exacerbate the dynamic infundibular obstruction. The murmur produced by the muscular obstruction is absent during a true spell, due to nearly absent antegrade flow across the right ventricular outflow tract. Patients become severely cyanotic, hyperpnoeic, and lethargic. With the development of metabolic acidosis, there is an increase in pulmonary vascular resistance, with a decrease in systemic vascular resistance. Cardiac output becomes compromised due to myocardial ischaemia. Impending collapse and death can ensue.
Aetiology and genetic counselling
The aetiology is multifactorial. Associated chromosomal anomalies can include trisomies 21, 18, and 13, but recent experience points to the much more frequent association of microdeletions of chromosome 22. As many as one-eighth of patients will have chromosomal abnormalities, such as trisomy 21, 18, or 13 . Up to one-fifth of patients with tetralogy and pulmonary stenosis, and two-fifths of those with tetralogy and pulmonary atresia, will have microdeletions of chromosome 22q11.2 [12, 20, 21]. The deletion, manifested by varying degrees of palatal abnormalities, dysmorphic facies, learning disabilities, immune deficiencies, and hypocalcaemia, is frequently referred to as the DiGeorge Syndrome.
The risk of recurrence in a family is approximately 3%.
Associations with maternal intake of retinoic acid during the first trimester, poorly controlled diabetes, and untreated phenylketonuria have also been described .
Tetralogy of Fallot can be diagnosed antenatally as early as 12 weeks of gestation . In a population-based study, however, only half of the cases were detected during routine obstetric ultrasonic screening . In general, patients who are referred for foetal echocardiography with a suspicion of tetralogy of Fallot have the most severe phenotypes . Other reasons for referral for foetal echocardiography include discovery of extra-cardiac malformations, or known chromosomal abnormalities. As a result, patients referred for foetal echocardiography tend to have worse outcomes when compared to patients who are diagnosed postnatally . The foetus with tetralogy can be delivered vaginally, but efforts should be made for delivery to occur in a centre where paediatric cardiologists are available to aid in the postnatal care.
The differential diagnosis of any cyanotic patient with a murmur will include persistent pulmonary hypertension of the newborn, as well as other cyanotic lesions such as critical pulmonary stenosis, Ebstein's malformation, transposed arterial trunks, common arterial trunk, totally anomalous pulmonary venous connection, and tricuspid atresia.
Clinical management is determined by the degree and type of subpulmonary obstruction, in combination with the preference of the centre for the timing of surgical intervention. Depending on the severity of obstruction within the subpulmonary outflow tract, an infusion of prostaglandin may be initiated to preserve ductal patency, and provide a stable source of flow of blood to the lungs. Patients who require such an infusion will most likely require surgical intervention prior to discharge from the hospital. For those patients who have adequate forward flow through the subpulmonary outflow tract after ductal closure, management consists of close follow-up until a complete repair is performed.
Some centres will perform complete repairs in all neonates. Others will palliate symptomatic neonates, and perform a complete repair in all patients at the age of 4 to 6 months.
Palliation, which frequently does not require cardiopulmonary bypass, establishes a secure source of flow of blood to the lungs by placing a prosthetic tube between a systemic and a pulmonary artery. The most common type of aorto-pulmonary shunt is known as the modified Blalock-Taussig shunt. This consists of a communication between a subclavian and pulmonary artery on the same side. A complete repair, always performed under cardiopulmonary bypass, consists of closing the interventricular communication with a patch channeling the left ventricle to the aortic root, relief of the subpulmonary obstruction, and reconstruction, if necessary, of the pulmonary arteries.
Complete neonatal repair provides prompt relief of the volume and pressure overload on the right ventricle, minimises cyanosis, decreases parental anxiety, and eliminates the theoretical risk of stenosis occurring in a pulmonary artery due to a palliative procedure. Patients who undergo a successful complete repair during the neonatal period will be unlikely to require more than one intervention in the first year of life, but are not free from reintervention. Concerns regarding such neonatal complete repairs include exposure of the neonatal brain to cardiopulmonary bypass, and the increased need to place a patch across the ventriculo-pulmonary junction when compared to older age at repair [24, 25]. Patches placed across the ventriculo-pulmonary junction, so-called transannular patches, create a state of chronic pulmonary regurgitation, which increases morbidity in young adults, producing exercise intolerance and ventricular arrhythmias. If left untreated, this increases the risk of sudden death [26–28]. The effect of cardiopulmonary bypass on the neonatal brain, and the associated risk of longer stay in hospital and the intensive care unit, is not trivial. Studies of neurodevelopmental outcomes of neonates undergoing cardiopulmonary bypass compared to older children have shown lower intelligence quotients in patients exposed to bypass as neonates . Longer periods of bypass, and longer stays in the intensive care unit, have been associated with an increased risk for neurological events and abnormal neurological findings on follow-up [30, 31]. While some studies have not found cyanosis itself to be responsible for cognitive problems in children with congenitally malformed hearts , others have implicated chronic cyanosis as a factor contributing to impaired motor skills, decreased academic achievement, and worsened behavioural outcomes [33, 34]. In the absence of randomised control trials, assessing the risk and benefits of the two surgical strategies has been notoriously difficult.
In summary, patients with cyanotic tetralogy of Fallot will either undergo neonatal complete repair or neonatal palliation with an aortopulmonary shunt followed by a complete repair at four to six months of age. Peri-operative mortality rates for either surgical approach is less than 3% [24, 25] and since neither strategy has shown superior results, surgical management remains dependent on the protocols preferred by the individual centres.
Management of the anatomical variants of tetralogy of Fallot
Neonates born with tetralogy of Fallot with pulmonary atresia who do not have stable flow to the lungs through collateral arteries will require surgical intervention prior to discharge from the hospital. In newborns with tetralogy of Fallot with absent pulmonary valve, surgical repair may be required prior to initial discharge from hospital if obstruction to the airways is a prominent symptom. In cases with tetralogy of Fallot with atrioventricular septal defect, complete repair is usually performed later in life compared to patients with uncomplicated tetralogy of Fallot, typically between the ages of 6 and 12 months. If significantly cyanotic at birth, most centres still opt for initial palliation rather than complete repair in these patients. Freedom from reoperation is decreased compared to patients with uncomplicated tetralogy of Fallot .
Management of the hypercyanotic spell
Overcoming a hypercyanotic spell requires maneuvers to re-establish adequate balance between the systemic and pulmonary flows. Treatment must focus on decreasing pulmonary, and increasing systemic, vascular resistance, hence promoting left to right flow across the ventricular septal defect and into the subpulmonary outlet.
Parents at home with a child suffering such spells are taught to place their child in the knee-to-chest position in an effort to increase systemic vascular resistance and promote systemic venous return to the right heart. This will theoretically increase intracardiac shunting from left-to-right across the interventricular communication, as well as increase the preload of the right ventricle. Emergency services should be contacted immediately.
Medical management will consist of establishing immediate intravenous access to allow prompt administration of fluids, which will improve right ventricular preload. Oxygen should be initiated to decrease peripheral pulmonary vasoconstriction, and improve oxygenation once flow of blood to the lungs is re-established. Subcutaneous morphine should be administered to decrease the release of catecholamines. This will increase the period of right ventricular filling by decreasing the heart rate, and promote relaxation of the infundibular spasm. If the patient remains hypercyanotic after these measures, he or she should be paralysed and intubated, with phenylephrine administered intravenously to increase systemic vascular resistance.
The long half-life, and potential side effects, such as hypotension and cardiac dysfunction, of beta blockers precludes their routine use in the emergency situation. Propranolol has been used in small doses in the chronic care of patients deemed to be at risk for spells in an effort to minimise the infundibular spasm responsible for the episodes. Once a patient requires prophylaxis by beta-blockade, surgical referral should occur to prevent the potential tragic and unpredictable outcome of a hypercyanotic spell .
Studies of immediate and long-term follow-up in tetralogy of Fallot reveal excellent outcomes. Patients born 30 years ago with tetralogy of Fallot have an 85% long-term rate of survival, and in the absence of serious residuae are able to lead normal lives as evidenced by the ability to carry successful pregnancies for example [35–40]. Chronic issues that face the current population of adults subsequent to their surgical repair include the haemodynamic manifestations of chronic pulmonary regurgitation, recurrent or residual pulmonary stenosis, and ventricular arrhythmias. The prognosis of patients born in the current era is expected to be substantially improved due to advances in surgical and medical management that have occurred over the past couple of decades. As for all patients with congenitally malformed hearts, the management of the patient with tetralogy of Fallot does not end at the time of complete repair. Follow-up by cardiologists trained in congenital cardiac disease will remain a life-long experience.
- Fallot ELA: Contribution a l'anatomie pathologique de la maladie bleu (cyanose cardiaque). Marseille Medical. 25: 77-93.
- Becker AE, Connor M, Anderson RH: Tetralogy of Fallot: a morphometric and geometric study. American Journal of Cardiology. 1975, 35: 402-412. 10.1016/0002-9149(75)90034-X.View ArticlePubMed
- Perry LW, Neill CA, Ferencz C, EUROCAT Working Party on. Congenital Heart Disease: Perspective in Pediatric Cardiology. Epidemiology of congenital heart disease, the Baltimore-Washington Infant Study 1981–89 Armonk, NY: Futura; 1993:33-62.
- Oppenheimer-Dekker A, Bartelings MM, Wenink ACG: Anomalous architecture of the ventricles in hearts with overriding of aortic valve and a perimembranous ventricular septal defect ("Eisenmenger VSD"). International Journal of Cardiology. 1989, 9: 341-355. 10.1016/0167-5273(85)90032-4.View Article
- Anderson RH, Weinberg PM: The clinical anatomy of tetralogy of Fallot. Cardiology in the Young. 2005, 15 (Suppl 1): 38-47. 10.1017/S1047951105001010.View ArticlePubMed
- Paediatric Cardiology 2nd edition. Edited by: Anderson RH, Baker EJ, Macartney FJ. London: Churchill Livingstone; 2002:1213-1280.
- Chowdhury UK, Mishra AK, Ray R, Kalaivani M, Reddy SM, Venugopal P: Histopathologic changes in ascending aorta and risk factors related to histopathologic conditions and aortic dilatation in patients with tetralogy of Fallot. Journal of Thoracic Cardiovascular Surgery. 2008, 135 (1): 69-77. 10.1016/j.jtcvs.2007.06.011.View ArticlePubMed
- Tan JL, Gatzoulis MA, Ho SY: Aortic root disease in tetralogy of Fallot. Current Opinion in Cardiology. 2006, 21 (6): 569-572. 10.1097/01.hco.0000245732.09594.2f.View ArticlePubMed
- Roekens CN, Zuckerber AL: Emergency management of hypercyanotic crises in tetralogy of Fallot. Annals of Emergency Medicine. 1995, 25 (2): 256-258. 10.1016/S0196-0644(95)70335-7.View ArticlePubMed
- Kothari SS: Mechanism of cyanotic spells in tetralogy of Fallot – the missing link?. International Journal of Cardiology. 1992, 37 (1): 1-5. 10.1016/0167-5273(92)90125-M.View ArticlePubMed
- Moss and Adam's Heart Disease in Infants, Children and Adolescents. Edited by: Allen HD, Clark EB, Gutgessell HP, et al. Philadelphia: Lippincott Williams and Wilkins; 2001:80-902.
- Critical Heart Disease in Infants and Children 2nd edition. Edited by: Nichols DG, Ungerleider RM, Spevall PJ. Philadelphia: Mosby; 2006:755-766.
- Alsoufi B, Williams WG, Hua Z, Cai S, Karamlou T, Chan CC, Coles JG, Van Arsdell GS, Caldarone CA: Surgical outcomes in the treatment of patients with tetralogy of Fallot and absent pulmonary valve. European Journal of Cardiothoracic Surgery. 2007, 31: 354-359. 10.1016/j.ejcts.2006.12.001.View ArticlePubMed
- Comprehensive Surgical Management of Congenital Heart Disease. Edited by: Jonas RA. New York: Oxford University Press; 2004:279-300.
- Karl TR: Atrioventricular septal defect with tetralogy of Fallot or double-outlet right ventricle: surgical considerations. Seminars in Thoracic Cardiovascular Surgery. 1997, 9 (1): 26-34.PubMed
- Chiu IS, Hung CR, Wang JK, Wu MH, Chu SH: Surgical treatment of complete atrioventricular septal defect associated with tetralogy of Fallot. International Journal of Cardiology. 1995, 48 (3): 225-230. 10.1016/0167-5273(94)02243-C.View ArticlePubMed
- Hoohenkerk GJ, Schoof PH, Bruggemans EF, Rijlaarsdam M, Hazekamp MG: 28 years' experience with transatrial-transpulmonary repair of atrioventricular septal defect with tetralogy of Fallot. The Annals of Thoracic Surgery. 2008, 85 (5): 1686-1689. 10.1016/j.athoracsur.2007.11.030.View ArticlePubMed
- Milo S, Ho SY, Macartney FJ, Wilkinson JL, Becker AE, Wenink ACG, Gittenberger-de Groot AC, Anderson RH: Straddling and overriding atrioventricular valves morphology and classification. American Journal of Cardiology. 1979, 44: 1122-1134. 10.1016/0002-9149(79)90178-4.View ArticlePubMed
- Pediatric ECG Interpretation. Edited by: Deal BJ, Johnsrude CL, Buck SH. Malden, Massachussetts: Blackwell Publishing; 2004:88-122.
- Maeda J, Yamagishi H, Matsuoka R, Ishihara J, Tokumura M, Fukushima H, Ueda H, Takahashi E, Yoshiba S, Kojima Y: Frequent association of 22q11.2 deletion with tetralogy of Fallot. American Journal of Medical Genetics. 2000, 92: 269-272. 10.1002/(SICI)1096-8628(20000605)92:4<269::AID-AJMG9>3.0.CO;2-L.View ArticlePubMed
- Khositseth A, Tocharoentanaphol C, Khowsathit P, Ruangdaraganon N: Chromosome 22q11 deletions in patients with conotruncal defects. Pediatric Cardiology. 2005, 26: 570-573. 10.1007/s00246-004-0775-5.View ArticlePubMed
- Poon LC, Huggon IC, Zidere V, Allan LD: Tetralogy of Fallot in the fetus in the current era. Ultrasound in Obstetrics and Gynecology. 2007, 29 (6): 625-627. 10.1002/uog.3971.View ArticlePubMed
- Chew C, Halliday JL, Riley MM: Population based study of antenatal detection of congenital heart disease by ultrasound examination. Ultrasound in Obstetrics and Gynecology. 2007, 29: 619-624. 10.1002/uog.4023.View ArticlePubMed
- Hirsch J, Mosca R, Bove E: Complete repair of tetralogy of Fallot in the neonate. Annals of Surgery. 2000, 232 (4): 508-514. 10.1097/00000658-200010000-00006.PubMed CentralView ArticlePubMed
- Stewart RD, Backer CL, Young L, Mavroudis C: Tetralogy of Fallot: Results of a pulmonary valve-sparing strategy. Annals of Thoracic Surgery. 2005, 80: 1431-1439. 10.1016/j.athoracsur.2005.04.016.View ArticlePubMed
- Nollert G, Fischlein T, Bouterwek S, Böhmer C, Klinner W, Reichart B: Long-term survival in patients with repair of TOF: 36-year follow-up of 490 survivors of the first year after surgical repair. The Journal of the American College of Cardiology. 1997, 30: 1374-1383. 10.1016/S0735-1097(97)00318-5.View ArticlePubMed
- Helbing WA, Roest AA, Niezen RA, Vliegen HW, Hazekamp MG, Ottenkamp J, de Roos A, Wall van der EE: ECG predictors of ventricular arrhythmias and biventricular size and wall mass in tetralogy of Fallot with pulmonary regurgitation. Heart. 2002, 88: 515-520. 10.1136/heart.88.5.515.PubMed CentralView ArticlePubMed
- Gatzoulis MA, Till JA, Somerville J, Redington AN: Mechanoelectrical interaction in tetralogy of Fallot, QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995, 92 (2): 231-237.View ArticlePubMed
- Miller G, Tesman JR, Ramer JC, Baylen BG, Myers JL: Outcome after open-heart surgery in infants and children. Journal of Child Neurology. 1996, 11 (1): 49-53. 10.1177/088307389601100112.View ArticlePubMed
- Limperopoulos C, Majnemer A, Shevell MI, Rohlicek C, Rosenblatt B, Tchervenkov C, Darwish HZ: Predictors of developmental disabilities after open heart surgery in young children with congenital heart defects. The Journal of Pediatrics. 2002, 141 (1): 52-58. 10.1067/mpd.2002.125227.View Article
- Fallon P, Aparício JM, Elliott MJ, Kirkham FJ: Incidence of neurological complications of surgery for congenital heart disease. Archives of Disease in Childhood. 1995, 72: 418-422. 10.1136/adc.72.5.418.PubMed CentralView ArticlePubMed
- Wright M, Nolan T: Impact of cyanotic heart disease on school performance. Archives of Disease in Children. 1994, 71: 64-70. 10.1136/adc.71.1.64.View Article
- Stieh J, Kramer HH, Harding P, Fischer G: Gross and fine motor development is impaired in children with cyanotic congenital heart disease. Neuropediatrics. 1999, 30 (2): 77-82. 10.1055/s-2007-973464.View ArticlePubMed
- Bass JL, Corwin M, Gozal D, Moore C, Nishida H, Parker S, Schonwald A, Wilker RE, Stehle S, Kinane TB: The effect of chronic or intermittent hypoxia on cognition in childhood: a review of the evidence. Pediatrics. 2004, 114: 805-816. 10.1542/peds.2004-0227.View ArticlePubMed
- A Alexiou C, Mahmoud H, Al-Khaddour A, Gnanapragasam J, Salmon AP, Keeton BR, Monro JL: Outcome after repair of Fallot in the first year of life. Annals of Thoracic Surgery. 2001, 71 (2): 494-500. 10.1016/S0003-4975(00)02444-9.View ArticlePubMed
- Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, Mayer JE, del Nido PJ, Jonas RA: Long-term results after early primary repair of tetralogy of Fallot. Journal of Thoracic and Cardiovascular Surgery. 2001, 122 (1): 154-161. 10.1067/mtc.2001.115156.View ArticlePubMed
- Cobanoglu A, Schultz JM: Total correction of tetralogy of Fallot in the first year of life: late results. Annals of Thoracic Surgery. 2002, 74 (1): 133-138. 10.1016/S0003-4975(02)03619-6.View ArticlePubMed
- Ternestedt BM, Wall K, Oddsson H, Riesenfeld T, Groth I, Schollin J: Quality of life 20 and 30 years after surgery in patients operated on for tetralogy of Fallot and for atrial septal defect. Pediatric Cardiology. 2001, 22 (2): 128-132. 10.1007/s002460010178.View ArticlePubMed
- Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK: Long term outcome in patients undergoing surgical repair of tetralogy of Fallot. New England Journal of Medicine. 1993, 329: 593-599. 10.1056/NEJM199308263290901.View ArticlePubMed
- Hövels-Gürich HH, Konrad K, Skorzenski D, Minkenberg R, Herpertz-Dahlmann B, Messmer BJ, Seghaye MC: Long-term behavior and quality of life after corrective cardiac surgery in infancy for tetralogy of Fallot or ventricular septal defect. Pediatric Cardiology. 2007, 28: 346-354. 10.1007/s00246-006-0123-z.View ArticlePubMed
- Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk AP, Spijkerboer AM, Bouma BJ, Zwinderman AH, Hazekamp MG, de Roos A, Mulder BJ: Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation. 2007, 116 (5): 545-551. 10.1161/CIRCULATIONAHA.106.659664.View ArticlePubMed
- Meadows J, Powell AJ, Geva T, Dorfman A, Gauvreau K, Rhodes J: Cardiac magnetic resonance imaging correlates of exercise capacity in patients with surgically repaired tetralogy of Fallot. American Journal of Cardiology. 2007, 100 (9): 1446-1450. 10.1016/j.amjcard.2007.06.038.View ArticlePubMed
- Schievano S, Coats L, Migliavacca F, Norman W, Frigiola A, Deanfield J, Bonhoeffer P, Taylor AM: Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. Journal of Cardiovascular Magnetic Resonance. 2007, 9 (4): 687-695. 10.1080/10976640601187596.View ArticlePubMed
- Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, Muthurangu V, Lee TY, Parenzan G, Derrick G, Cullen S, Walker F, Tsang V, Deanfield J, Taylor AM, Bonhoeffer P: Percutaneous pulmonary valve implantation. Impact of evolving technology and learning curve on clinical outcome. Circulation. 2008, 117: 1964-1972. 10.1161/CIRCULATIONAHA.107.735779.View ArticlePubMed
- Frigiola A, Tsang V, Nordmeyer J, Lurz P, van Doorn C, Taylor AM, Bonhoeffer P, de Leval M: Current approaches to pulmonary regurgitation. European Journal of Cardiothoracic Surgery. 2008, 34 (3): 576-580. 10.1016/j.ejcts.2008.04.046.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.